5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Meeting Abstract

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z. X.; Tallman, M. S.; Patel, J. P.; Gonen, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Glutamine based pet imaging facilitates enhanced metabolic fetection of gliomas in vivo
    Meeting Abstract

    Venneti, S.; Dunphy, M.; Zhang, H. W.; Pitter, K.; Campos, C.; Carlin, S.; Lyashchenko, S.; Ploessl, C.; Rohle, D.; Omuro, A.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; Patel, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation
    Meeting Abstract

    Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, a small molecule mutant IDH2 inhibitor, remodels the epigenetic state of IDH2-mutant cells and induces alterations in self-renewal/differentiation in IDH2-mutant AML model in vivo
    Meeting Abstract

    Shih, A. H.; Shank, K. R.; Meydan, C.; Intlekofer, A. M.; Ward, P.; Thompson, C. B.; Melnick, A. M.; Travins, J.; Straley, K.; Gliser, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Mutation profiling of therapy-related myeloid neoplasms using next-generation sequencing demonstrates distinct profiles from de novo disease
    Meeting Abstract

    Shih, A. H.; Rapaport, F.; Chung, S. S.; Dolezal, E. K.; Hobson, S.; Amato, M. K.; Park, C. Y.; Sekeres, M. A.; van den Brink, M. R. M.; Nimer, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Mathematical optimization of JAK inhibitor dose and scheduling for MPN patients
    Meeting Abstract

    Shank, K. R.; Koppikar, P.; Bhagwat, N.; Keller, M. D.; Michor, F.; Levine, R. L.; Roditi, L. D.
    Blood (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid lukemia
    Meeting Abstract

    Rampal, R. K.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J. P.; Li, Y. S.; Ahn, J.; Abdel-Wahab, O.; Shih, A. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The significance of GADD45A promoter DNA hypermethylation in AML: Association with IDH1/2 and TET2 mutation
    Meeting Abstract

    Perugini, M.; Samaraweera, S. E.; Brown, A. L.; Cummings, N.; Danner, S.; Tiong, I. S.; Garrett-Bakelman, F. E.; Carroll, M. P.; Becker, M. W.; Chung, S. S.; more...
    Blood (2014)

    Fulltext@MSK | Save